Hatch-Waxman and BPCIA Cases and Trends to Watch in 2021By: W. Blake Coblentzon January 25, 2021 at 12:15 pm Publication: IPWatchdog.com | Patents & Patent Law

As we turn the page to 2021, we expect at least two major cases to be resolved that could have long-lasting effects on where and how Hatch-Waxman and Biologics Price Competition and Innovation Act (BPCIA) cases are litigated. Specifically, the future of skinny labels is in doubt, and available venue  Read More>>

Categories   Courts, District Courts, Federal Circuit, Guest Contributors, IP News, IPWatchdog Articles, Litigation, Patents, Biologics Price Competition and Innovation Act, biosimilars, CAFC, generic drugs, Guest Contributor, Hatch-Waxman Act, intellectual property, patent, patent infringement, Patent Litigation, patents, skinny labels